T cell development, ageing and Interleukin-7

Mechanisms of Ageing and Development
Richard Aspinall

Abstract

Interleukin-7 (IL-7) is a cytokine with a central role in the development and maintenance of the peripheral T cell pool. In the mouse, expression of the IL-7 gene in the thymus has been carefully followed from gestation onwards throughout the lifespan. One of the features of its expression in the thymus is that it changes with time, declining measurably as the animal ages. This reduction is associated with a decrease in thymic size, cellularity and output. Analysis of transgenic animals carrying either IL-7 or IL-7 receptor transgenes reveals that the intrathymic level of IL-7 has a critical effect on the production of T cells, and that this may not be a linear relationship. This is an important consideration for therapy involving treatment of old animals with IL-7 of which there are reports indicating some rejuvenation of the thymus following IL-7 treatment, which is never complete. The thymus does not appear to return to the size and cellularity seen in youth. Several possible scenarios could account for this, including the inability to maintain IL-7 within defined limits in the thymus during the therapy.

References

Apr 1, 1992·European Journal of Immunology·M V WilesB A Imhof
Apr 1, 1995·The Journal of Experimental Medicine·S K BhatiaT J Waldschmidt
Apr 1, 1995·The Journal of Experimental Medicine·U von Freeden-JeffryR Murray
Feb 1, 1995·European Journal of Immunology·L A AlvesW Savino
Nov 1, 1994·The Journal of Experimental Medicine·J J PeschonB L Davison
Aug 1, 1993·The Journal of Experimental Medicine·H T PetrieK Shortman
Jan 1, 1996·Annual Review of Immunology·K Shortman, L Wu
Oct 10, 1996·Developmental Biology·M D MichaelsonJ A Kessler
Jan 5, 2002·Experimental Gerontology·Deborah Andrew, Richard Aspinall
May 16, 2002·Blood·Terry J Fry, Crystal L Mackall
Oct 2, 2002·European Journal of Immunology·Jeffrey Pido-LopezRichard Aspinall
Nov 13, 2002·Journal of Hematotherapy & Stem Cell Research·Terry J Fry, Crystal L Mackall
Jan 7, 2003·Nature Immunology·David AllmanAvinash Bhandoola
Dec 6, 2003·The Journal of Allergy and Clinical Immunology·Tania HabibKenneth Kaushansky
Dec 23, 2003·Journal of the American Geriatrics Society·Bobbi Langkamp-HenkenSteven M Wood
May 25, 2004·Blood·Nahed El KassarRonald E Gress
Jul 23, 2004·Expert Opinion on Biological Therapy·Thomas J Conlon, Terence R Flotte
Apr 21, 2005·The Journal of Clinical Investigation·Fraia MelchiondaCrystal L Mackall

❮ Previous
Next ❯

Citations

Dec 31, 1998·Arthritis and Rheumatism·T NamekawaC M Weyand
Jan 24, 2009·Proceedings of the National Academy of Sciences of the United States of America·Nuno L AlvesJames P Di Santo
Aug 14, 2009·Rejuvenation Research·Manuela Zlamy, Martina Prelog
Nov 14, 2008·Stem Cells and Development·Moubarak MouiseddineJean-Marc Bertho
Nov 29, 2008·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Marta EspíaJorge Lloberas
Sep 15, 2009·International Immunology·Hamid MattooVineeta Bal
Jun 28, 2006·Immunity & Ageing : I & a·Eugenio MocchegianiGraham Pawelec
Aug 24, 2010·Immunity & Ageing : I & a·Régine Minet-QuinardM Paule Vasson
Nov 30, 2007·Clinical Interventions in Aging·Tamas FülöpGraham Pawelec
May 1, 2009·Journal of Immunotoxicology·Denise L BellingerDianne Lorton
May 1, 2008·Expert Review of Vaccines·Rajesh Kumar, Edith A Burns
Apr 15, 2008·Expert Opinion on Biological Therapy·Susmit Suvas
Apr 18, 2012·Expert Opinion on Biological Therapy·Marie KorabecnaVladimir Tesar
Nov 21, 2015·Organogenesis·Elizabeth C Stahl, Bryan N Brown
Apr 2, 2010·Trends in Immunology·Jarrod A DudakovAnn P Chidgey
Jun 23, 2009·Trends in Immunology·Mark R Dowling, Philip D Hodgkin
Nov 4, 2008·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Martina PrelogBeatrix Grubeck-Loebenstein
Jul 1, 2008·The Journal of Pediatrics·May-Lill GarlyIda Maria Lisse
May 31, 2008·Journal of Autoimmunity·Grant MorahanRob Williams
Oct 30, 2015·Early Human Development·Giovanni AlmanzarMartina Prelog
Jul 23, 2009·Journal of Internal Medicine·C M CapitiniC L Mackall
Nov 8, 2007·Annals of the New York Academy of Sciences·Sven KochGraham Pawelec
Feb 23, 2007·Immunology·Danielle AwDonald B Palmer
Jul 22, 2008·Experimental Cell Research·Shengjun QiaoMikael Jondal
Apr 11, 2008·Physiology·Anis LarbiGraham Pawelec
Dec 21, 2011·Journal of Immunoassay & Immunochemistry·Marisa PalmeriDomenico Lio
Apr 25, 2018·Frontiers in Immunology·Irene Maeve ReaOwen A Ross
Aug 22, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Laetitia GautreauSophie Ezine

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.